Europe — EMA
Voluven (Sodium Chloride, Hydroxyethyl Starch 130/0.4)
Voluven is a balanced electrolyte solution with hydroxyethyl starch used for plasma volume expansion in clinical settings. It helps maintain fluid balance durin
Request sourcing
What is Sodium Chloride, Hydroxyethyl Starch 130/0.4?
Voluven is a balanced electrolyte solution with hydroxyethyl starch used for plasma volume expansion in clinical settings. It helps maintain fluid balance during medical procedures or conditions causing low blood volume. Suitable for intravenous administration under professional supervision.
What is Sodium Chloride, Hydroxyethyl Starch 130/0.4 used for?
Voluven is commonly used to restore and maintain plasma volume in patients experiencing hypovolemia or undergoing surgical procedures where fluid loss is expected. It is also utilized in intensive care settings to support circulatory function during critical conditions. Healthcare providers may prescribe it for conditions requiring temporary plasma volume expansion.
What are the side effects of Sodium Chloride, Hydroxyethyl Starch 130/0.4?
As a plasma volume expander, Voluven helps increase blood volume, improving circulation and organ perfusion. Patients may experience improved hydration and stability in blood pressure during treatment. The solution is designed to mimic natural plasma, supporting the body’s fluid balance temporarily.
What precautions apply to Sodium Chloride, Hydroxyethyl Starch 130/0.4?
Voluven should only be administered by healthcare professionals in a controlled clinical environment. Patients with severe kidney impairment or fluid overload conditions should use it with caution. Regular monitoring of fluid balance and kidney function is recommended during treatment.
What does Sodium Chloride, Hydroxyethyl Starch 130/0.4 interact with?
Voluven may interact with other intravenous fluids or medications that affect fluid balance, such as diuretics or blood products. Combining it with incompatible solutions could alter its effectiveness or safety. Always inform healthcare providers about all medications and conditions before administration.


